No substrate information.
Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
SLC22A1 |
OCT1 |
Dipyridamole |
81 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-OCT1 |
Kido, 2011 |
SLC47A1 |
MATE1 |
Dipyridamole |
24 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE1 |
Kido, 2011 |
SLC47A1 |
MATE1 |
Dipyridamole |
26 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE1 |
Kido, 2011 |
SLC47A2 |
MATE2K |
Dipyridamole |
74 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-MATE2K |
Kido, 2011 |
ABCC4 |
MRP4 |
Dipyridamole |
2 |
|
9-(2-phosphonomethoxyethyl)adenine (PMEA) |
MRP4-expressing HEK293 vesicles |
Reid, 2003 |
ABCC5 |
MRP5 |
Dipyridamole |
30 |
|
9-(2-phosphonomethoxyethyl)adenine (PMEA) |
MRP4-expressing HEK293 vesicles |
Reid, 2003 |
ABCC4 |
MRP4 |
Dipyridamole |
<20 |
|
Cholyltaurine |
MRP4-expressing V79 vesicles |
Rius, 2003 |
SLC22A4 |
OCTN1 |
Dipyridamole |
0.0077 |
|
Cytarabine |
HEK293-hOCTN1 |
Drenberg, 2017 |
ABCB1 |
MDR1, P-gp |
Dipyridamole |
22.7 |
|
Daunorubicin |
NIH-3T3-G185 cells |
Wang, 2001 |
SLCO2B1 |
OATP2B1, OATP-B |
Dipyridamole |
2 |
|
Dibromofluorescein |
HEK293-OATP2B1 |
Unger, 2020 |
ABCB1 |
MDR1, P-gp |
Dipyridamole |
40 |
|
Digoxin |
MDR1 transfected LLC-PK1 |
Kakumoto, 2002 |
ABCC4 |
MRP4 |
Dipyridamole |
8.3 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC2 |
MRP2, cMOAT |
Dipyridamole |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC3 |
MRP3 |
Dipyridamole |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCB1 |
MDR1, P-gp |
Dipyridamole |
23.7 |
|
LDS-751 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB1 |
MDR1, P-gp |
Dipyridamole |
34.3 |
|
Rhodamine 123 |
NIH-3T3-G185 cells |
Wang, 2001 |
ABCB11 |
BSEP |
Dipyridamole |
4 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
No drug-drug interaction information.